Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
Dr Clément BECLE Cardiologique – Centre Cardiologique de l’Ouest Lyonnais – Lyon
